Skip to main content


Page 29 of 29

  1. For patients who require replacement therapy for primary immunodeficiency, subcutaneous infusions of immunoglobulin G (IgG) may be preferable to intravenous infusions for several reasons. However, at present, ...

    Authors: Akhilesh Chouksey, Kimberly Duff, Nancy Wasserbauer and Melvin Berger
    Citation: Allergy, Asthma & Clinical Immunology 2005 1:120
  2. More and more studies are demonstrating interactions between the nervous system and the immune system. However, the functional relevance of this interaction still remains to be elucidated. Such associations ha...

    Authors: Hanneke PM van der Kleij and John Bienenstock
    Citation: Allergy, Asthma & Clinical Immunology 2005 1:65
  3. Asthma is a very common disorder that still causes significant morbidity and mortality. A high percentage of individuals with asthma also experience exercise-induced bronchoconstriction (EIB). This article rev...

    Authors: George S Philteos, Beth E Davis, Donald W Cockcroft and Darcy D Marciniuk
    Citation: Allergy, Asthma & Clinical Immunology 2005 1:60
  4. Hypersensitivity to bloodworms (chironomid larvae) leading to asthma and other related allergic disorders is becoming common in individuals who keep or work with fish due to the increased use of bloodworms as ...

    Authors: Keith CP Wu, Katja Räsänen and Thomas J Hudson
    Citation: Allergy, Asthma & Clinical Immunology 2005 1:58
  5. Both B-lymphoblastoid cell lines and tonsillar B lymphocytes express receptors for platelet-activating factor (PAF). In lymph node germinal centres, B lymphocytes interact with follicular dendritic cells (FDCs...

    Authors: Isaac Halickman, Yolande Bastien, Qianli Zhuang, Monty B Mazer, Baruch Toledano and Bruce D Mazer
    Citation: Allergy, Asthma & Clinical Immunology 2005 1:49
  6. Numerous recombinant therapies are being investigated for the treatment of asthma. This report reviews the current status of several of these novel agents. Anti-immunoglobulin (Ig)E (omalizumab, Xolair) marked...

    Authors: Donald W Cockcroft
    Citation: Allergy, Asthma & Clinical Immunology 2004 1:34
  7. The surgical management of chronic rhinosinusitis has evolved considerably in the last decade. We currently have a more refined understanding of the various disease entities that make up the generic diagnosis ...

    Authors: Erin D Wright and Saul Frenkiel
    Citation: Allergy, Asthma & Clinical Immunology 2004 1:21

The official journal of CSACI

Annual Journal Metrics

  • 2022 Citation Impact
    2.7 - 2-year Impact Factor
    3.4 - 5-year Impact Factor
    0.989 - SNIP (Source Normalized Impact per Paper)
    0.634 - SJR (SCImago Journal Rank)

    2022 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    133 days submission to accept (Median)

    2022 Usage 
    5,769 Altmetric mentions